Clearside Biomedical, Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Exchange Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (9)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (5)
- Form of Securities Purchase Agreement, dated February 6, 2024 by and among Clearside Biomedical, Inc. and the purchasers party thereto (Filed With SEC on February 8, 2024)
- Form of Warrant (Filed With SEC on February 8, 2024)
- Purchase and Sale Agreement, by and among Clearside Royalty LLC, Healthcare Royalty Partners IV, L.P. and HCR Collateral Management, LLC (in its capacity as agent for Purchaser),... (Filed With SEC on November 9, 2022)
- Consent and Fifth Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of March 11, 2020 (Filed With SEC on May 8, 2020)
- Consent and Fourth Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of October 22, 2019 (Filed With SEC on March 13, 2020)
- Third Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of October 18, 2019 (Filed With SEC on March 13, 2020)
- Description of Common Stock of Clearside Biomedical, Inc (Filed With SEC on March 13, 2020)
- Registration Rights Agreement, dated November 22, 2019, by and among the Company and the other parties thereto (Filed With SEC on November 25, 2019)
- Securities Purchase Agreement, dated November 22, 2019, by and among the Company and the other parties thereto (Filed With SEC on November 25, 2019)
- Consent and Second Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of August 29, 2019 (Filed With SEC on November 8, 2019)
- Consent and First Amendment to Second Amended and Restated Loan and Security Agreement, by and between the Registrant and Silicon Valley Bank, dated as of July 3, 2019 (Filed With SEC on August 8, 2019)
- Second Amended and Restated Loan and Security Agreement, dated as of May 14, 2018, by and among the Registrant, Silicon Valley Bank, MidCap Funding III Trust and MidCap Financial... (Filed With SEC on May 15, 2018)
- Underwriting Agreement by and among Clearside Biomedical, Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC, dated March 7, 2018 (Filed With SEC on March 8, 2018)
- First Amendment to Amended and Restated Loan and Security Agreement, by and among the Company, Silicon Valley Bank, ELM 2016-1 Trust and Midcap Financial Trust, dated as of... (Filed With SEC on November 2, 2017)
- [] Shares Clearside Biomedical, Inc. Common Stock ($0.001Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on December 7, 2016)
- AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on October 4, 2016)
- WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 4, 2016)
- Shares Clearside Biomedical, Inc. Common Stock ($0.001Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on May 11, 2016)
- CLEARSIDE BIOMEDICAL, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 21, 2016 APPROVED BY THE STOCKHOLDERS:[ ], 2016 (Filed With SEC on March 18, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on January 8, 2016)
- LICENSE AGREEMENT by and between CLEARSIDE BIOMEDICAL, INC. and NOVAMEDICA LLC Confidential andProprietary CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT.... (Filed With SEC on January 8, 2016)
- WARRANT TO PURCHASE STOCK (Filed With SEC on January 8, 2016)
- STOCK WARRANT (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on January 8, 2016)
- CLEARSIDE BIOMEDICAL, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT November 23, 2015 CLEARSIDE BIOMEDICAL, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 8, 2016)